Transpara is an AI-enabled medical device from Screenpoint Medical B.V., listed by FDA (510(k), K192287) with a decision date of 2019-12-10. Review panel: Radiology.
| FDA submission number | K192287 |
|---|---|
| Pathway | 510(k) |
| Company | Screenpoint Medical B.V. |
| Review panel (specialty) | Radiology |
| FDA decision date | 2019-12-10 |
| Decision | Substantially Equivalent |
| Product code | QDQ |
| Classification | Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer |
| Device class | 2 |
| Regulation number | 892.2090 |
| Review time (calendar days) | 110 |
| Applicant country | NL |
Official FDA database record · FDA AI-enabled device list
More devices from Screenpoint Medical B.V. · All Radiology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.